11/6/2025Innorna Reportedly Targets $200M Hong Kong IPO to Accelerate Drug Deve...

11/6/2025Clariant Completes Expansion of Pharma Excipients and Specialty Chemic...

11/6/2025AstraZeneca Adds CNY 990M Investment to Qingdao Inhalants Plant

11/6/2025Lilly Expands AI Collaboration with XtalPi, Ends CNS Research Pact wit...

11/6/2025Ivacta Raises CNY 100M+ in Angel Round Led by Qiming Venture Partners

11/6/2025China Grants Conditional Approval for ACEA's COVID-19 Antiviral Olgotr...

11/6/2025Novartis Wins China Approval for Two Pluvicto Indications

11/6/2025Dermavon Files for Hong Kong IPO to Advance Innovative Skin Health Por...

11/6/2025Suzhou Ribo Life Science Files for Hong Kong IPO as siRNA Pipeline Adv...

11/6/2025BrightGene Advances Metabolic Drug Pipeline as It Files for Hong Kong ...

11/5/2025AbbVie's CD20×CD3 Bispecific Epcoritamab Fails to Win China Approval

11/5/2025Lumosa's Stroke Drug Achieves Phase IIb Success in China

11/5/2025China Expands Drug Access Through 11th National Bulk-Buy and New 2025 ...

11/5/2025Senior CSPC Executive Fined CNY 5M for Insider Trading

11/5/2025Bayer Deepens Investment in China's Booming Biopharma Sector

11/5/2025China to Expand Use of Artificial Intelligence Across Health Sector by...

11/5/2025CDE Grants Breakthrough Therapy Designation to Ivonescimab for Triple-...

11/5/2025US Dollar Funds Make a Comeback in China's Innovative Drug Market: VBD...

11/5/2025TransThera Signs up to US$881.5M Global Deal with Neurocrine for NLRP...

11/5/2025Merck Secures $700M Funding from Blackstone for TROP2-Targeting ADC C...

11/5/2025CSL Behring Expands Partnership with Baiyang Pharma for Albumin Produc...

11/4/2025China's BMI Fund Maintains Strong Surplus in First Three Quarters of 2...

11/4/2025NHSA Introduces New Measure to Strengthen Intelligent Oversight of Exc...

11/4/2025CDE Invites Comments on the Draft Technical Guidelines for Dose Extrap...

11/4/2025CDE Seeks Comments on the 100th Batch of Reference Formulations for Ch...

11/4/2025Lepu Licenses GLP-1/GIP/FGF21 Agonist MWN105 to Sidera in US$1.05B Dea...

11/4/2025Huadong Medicine Initiates Phase I Trial of CDH17-Targeting ADC HDM201...

11/4/2025NovaBridge Biosciences (I-Mab) Files for Hong Kong IPO

11/4/2025Alebund Pharma's Hong Kong IPO Application Accepted

11/4/2025Lupeng Pharma's Hong Kong IPO Application Accepted

Page:1/59 Total number of articles:1744: [First][<<] [1] [2] [3] [4] [5] [>>] [End]